Government contract momentum: USDA $300M, NIH ARPA-H, Pentagon Maven, Army NGC2; FASA challenge against DIA ASTRA; Oracle $7B Pentagon deal
Key Questions
What recent government contract wins has Palantir secured?
Palantir won a $300M USDA BPA, a $13.7M NIH ARPA-H contract, Pentagon Maven work, and Army NGC2. Government revenue rose 84% YoY to $687M.
What happened with the DIA ASTRA solicitation?
Palantir invoked FASA to challenge the solicitation, leading the DIA to withdraw it. This procedural win reinforced the company's moat and the stock rose 1% pre-market on the news.
How is Palantir's government moat evolving?
The moat is now framed as a combination of legal precedent from FASA challenges and high data switching costs. The company increased defense lobbying spending to $2.08M.
What is the significance of Oracle's Pentagon deal for Palantir?
The up-to-$7B Oracle agreement signals accelerating government AI spending. Retail traders view it as a positive read-through that could benefit PLTR and similar contractors.
When is the GAO ruling expected on the FASA matter?
A GAO ruling is anticipated by October 28 and could further clarify Palantir's competitive position in government contracting.
USDA $300M BPA, NIH ARPA-H $13.7M, Pentagon Maven, Army NGC2 win. Government revenue up 84% YoY to $687M. Palantir invoked FASA to challenge DIA's ASTRA solicitation; DIA withdrew, a procedural win reinforcing moat. Stock rose 1% pre-market. GAO ruling by Oct 28. Oracle's $7B Pentagon deal signals accelerating government AI spending. Preview estimates Q2 government revenue at $1.03B total, suggesting strong acceleration.